Storia in 3 fonti

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

US tariff increases on generic medicines will lead to higher drug prices in India. Dr Reddy's Laboratories CEO Erez Israeli stated relocation to the US is impractical. The company will observe evolving situations without taking immediate special actions. Additional costs are anticipated due to the proposed tariff changes. Partnerships and contract manufacturing in the US remain possibilities if beneficial.

Raccontata da

economictimes.indiatimes.com

asia.nikkei.com

timesofindia.indiatimes.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo9 h fa

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

originale

timesofindia.indiatimes.com9 h fa

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

The US is putting generic medicines on the tariff map, with duties set to rise to as much as 200% in the coming years to boost local manufacturing. But will the cure soothe the pain for American consumers—or inflame it…

Timeline cronologica

mercoledì 22 luglio 2026·economictimes.indiatimes.com
200% Trump tariff shock? India’s cheap pills may still beat US rivals
US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Indian pharma firms may yet survive Trump's 200% tariff bombshell
Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Confronto fonti

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Timeline cronologica

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Trump's generic drugs tariff threatens Indian pharma's top market

Trump's generic drugs tariff threatens Indian pharma's top market

US tariffs could raise drug prices, squeeze Indian generics

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Pharma companies in a flux over Trump's 200% tariff move on generics

Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practical